105 related articles for article (PubMed ID: 2249891)
1. Potentiation of TNF-mediated cell killing by VP-16: relationship to DNA single-strand break formation.
Branellec D; Markovits J; Chouaib S
Int J Cancer; 1990 Dec; 46(6):1048-53. PubMed ID: 2249891
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
Utsugi T; Mattern MR; Mirabelli CK; Hanna N
Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formation.
Valenti M; Cimoli G; Mariani GL; Conte PF; Parodi S; Russo P
Biochem Pharmacol; 1993 Oct; 46(7):1199-206. PubMed ID: 8216370
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
[TBL] [Abstract][Full Text] [Related]
5. Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
Dorr RT; Liddil JD; Gerner EW
Cancer Res; 1986 Aug; 46(8):3891-5. PubMed ID: 3015379
[TBL] [Abstract][Full Text] [Related]
6. Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16.
Petersen LN; Jensen PB; Sørensen BS; Engelholm SA; Spang-Thomsen M
Invest New Drugs; 1994; 12(4):289-97. PubMed ID: 7775129
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
8. Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.
Kamath N; Grabowski D; Ford J; Drake F; Kerrigan D; Pommier Y; Ganapathi R
Cancer Commun; 1991 Feb; 3(2):37-44. PubMed ID: 1995027
[TBL] [Abstract][Full Text] [Related]
9. DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.
Sinha BK; Haim N; Dusre L; Kerrigan D; Pommier Y
Cancer Res; 1988 Sep; 48(18):5096-100. PubMed ID: 2842045
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaks.
Chiron M; Demur C; Pierson V; Jaffrezou JP; Muller C; Saivin S; Bordier C; Bousquet C; Dastugue N; Laurent G
Blood; 1992 Sep; 80(5):1307-15. PubMed ID: 1515645
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of epipodophyllotoxin-induced cell death in poly(adenosine diphosphate-ribose) synthesis-deficient V79 Chinese hamster cell lines.
Chatterjee S; Trivedi D; Petzold SJ; Berger NA
Cancer Res; 1990 May; 50(9):2713-8. PubMed ID: 2328496
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide.
Sinha BK; Politi PM; Eliot HM; Kerrigan D; Pommier Y
Eur J Cancer; 1990; 26(5):590-3. PubMed ID: 2169277
[TBL] [Abstract][Full Text] [Related]
13. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
[TBL] [Abstract][Full Text] [Related]
14. Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate.
Lorico A; Boiocchi M; Rappa G; Sen S; Erba E; D'Incalci M
Int J Cancer; 1990 Jan; 45(1):156-62. PubMed ID: 2153635
[TBL] [Abstract][Full Text] [Related]
15. DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA.
Walles SA; Zhou R; Liliemark E
Cancer Lett; 1996 Aug; 105(2):153-9. PubMed ID: 8697438
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
[TBL] [Abstract][Full Text] [Related]
17. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16).
Sehested M; Jensen PB; Sørensen BS; Holm B; Friche E; Demant EJ
Biochem Pharmacol; 1993 Aug; 46(3):389-93. PubMed ID: 8394080
[TBL] [Abstract][Full Text] [Related]
19. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
Ritke MK; Allan WP; Fattman C; Gunduz NN; Yalowich JC
Mol Pharmacol; 1994 Jul; 46(1):58-66. PubMed ID: 8058057
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
Jensen PB; Sørensen BS; Demant EJ; Sehested M; Jensen PS; Vindeløv L; Hansen HH
Cancer Res; 1990 Jun; 50(11):3311-6. PubMed ID: 2159380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
